Tag Archives: Alzheimer’s Moonshot

How Optoceutics Is Exploring the Power of Light Therapy Beyond Mood Enhancement

Business, Health, Innovation, Startups, , , , , , , ,

Podcast: Play in new window | Download ()

Subscribe: Spotify | iHeartRadio | Email | Deezer | RSS | More

We all know light therapy can brighten our mood, especially for those battling depression or seasonal affective disorder. But what if light could do so much more? In this week’s episode of StartUp Health NOW, we dive deep into the revolutionary work of StartUp Health community member Mai Nguyen, PhD, CEO & Co-founder of Optoceutics.

Forget what you think you know about light therapy. Nguyen and her team are pioneering a new frontier, demonstrating how precisely delivered light, through the eyes, can actually reprogram brain waves. This isn’t just about mood enhancement; it’s about potentially slowing the progression of neurodegenerative diseases like Alzheimer’s.

Join us for a fascinating conversation with Nguyen, a Berkeley researcher turned entrepreneur, as she discusses her groundbreaking device, currently marketed as a wellness tool, but with profound clinical aspirations. Discover how her collaboration with engineers in Copenhagen has led to a novel technology that’s already making waves.

This episode will challenge your perception of the lights around you and illuminate the future of brain health. Get ready to have your mind blown!

Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is a benefit of our Health Moonshot Community Membership. To schedule a call and see if you qualify to join and increase brand awareness through our multi-media storytelling efforts, submit our three-minute application. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit.
» Learn more and apply today.

Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

Early Detection, Better Outcomes: Transforming Alzheimer’s Diagnosis with Cx Precision Medicine

Early Detection, Better Outcomes: Transforming Alzheimer’s Diagnosis with CxPM

Business, Health, Innovation, Startups, , , , , , ,

Podcast: Play in new window | Download (34.9MB)

Subscribe: Spotify | iHeartRadio | Email | Deezer | RSS | More

Imagine this: 73 million Americans are over 65. Among them, 10-20% experience mild cognitive impairment (MCI), a potential precursor to Alzheimer’s. Yet their primary care doctors, with only 14 minutes per patient, lack the time for crucial neurological screenings. This is a critical gap in our healthcare system, especially as groundbreaking Alzheimer’s research and therapies emerge, making early detection more vital than ever.

That’s where Cx Precision Medicine comes in.

In this episode, we sit down with Sid O’Bryant, PhD, and Danguole Altman, the team behind CxPM, a company in the StartUp Health Alzheimer’s Moonshot Community working to revolutionize early cognitive screening with a simple blood test. Their innovative diagnostic tool is designed to detect neurodegenerative diseases earlier, ensuring patients get the right care at the right time.

O’Bryant’s extensive research, now commercialized by Altman’s leadership, offers a powerful tool for personalized care, enabling earlier, more accurate diagnoses of neurodegenerative diseases. We’ll dive into their unique journeys, the science behind their innovative blood test, and how it’s poised to transform patient care.   

Discover how Cx Precision Medicine is empowering patients to get the right care at the right time, streamlining the diagnostic process and ultimately, improving lives. Join us as we explore the future of Alzheimer’s detection and the hope it brings.

Let’s get into it!

Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is a benefit of our Health Moonshot Community Membership. To schedule a call and see if you qualify to join and increase brand awareness through our multi-media storytelling efforts, submit our three-minute application. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit.
» Learn more and apply today.

Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

REGEnLIFE: Pioneering Light Therapy in the Fight Against Alzheimer's

Can Light Therapy Slow Alzheimer’s? The Science of Photobiomodulation with Guillaume Blivet of REGEnLIFE

Business, Health, Innovation, Startups, , , , , ,

Podcast: Play in new window | Download (35.9MB)

Subscribe: Spotify | iHeartRadio | Email | Deezer | RSS | More

On this episode of StartUp Health NOW, we learn about the power of photobiomodulation, a light therapy that promotes healing at the cellular level. From treating seasonal affective disorder to wound healing, light therapy’s applications are expanding. We’re joined by Guillaume Blivet of REGEnLIFE, a member of the StartUp Health community who is pioneering research into using photobiomodulation to address Alzheimer’s disease. Learn how their unique approach, targeting both the brain and gut, shows promise in reducing inflammation and improving cellular health. We discuss the science, the promising early results, and the potential of this groundbreaking approach.

  • Unveiling Photobiomodulation:
    • Dive into the science of photobiomodulation, a cutting-edge light therapy that stimulates cellular healing at the molecular level.
    • Explore how specific wavelengths of red and near-infrared light can trigger biological responses, reducing inflammation and promoting cellular health.
  • Beyond Traditional Light Therapy:
    • Discover how researchers are pushing the boundaries of light therapy beyond seasonal affective disorder and dermatology.
    • Learn about innovative applications of photobiomodulation for internal therapeutic benefits.
  • REGEnLIFE’s Revolutionary Approach:
    • Meet Guillaume Blivet, co-founder of REGEnLIFE, and his team’s pioneering work in applying photobiomodulation to combat Alzheimer’s disease.
    • Explore their unique strategy of targeting both the brain and the gut simultaneously, leveraging the crucial gut-brain connection.
    • Learn about the animal studies that have shown promising results.
  • Innovation in Alzheimer’s Treatment:
    • Understand how REGEnLIFE’s photobiomodulation therapy aims to slow the progression of Alzheimer’s by reducing neuroinflammation and enhancing cellular function.
    • Hear about the ongoing human trials in France and the potential for this non-invasive, safe treatment to transform Alzheimer’s care.

Tune in now as we learn how targeting the gut-brain connection with specific wavelengths of light could offer new hope for patients.

 

Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is a benefit of our Health Moonshot Community Membership. To schedule a call and see if you qualify to join and increase brand awareness through our multi-media storytelling efforts, submit our three-minute application. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit.
» Learn more and apply today.

Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

 

Veravas Improves Diagnostic Tests by Purifying Samples

How Veravas Brings Clarity to Diagnostics by Cleaning Samples

Business, Health, Innovation, Startups, , , , , , , , , ,

Podcast: Play in new window | Download (Duration: 31:08 — 42.8MB)

Subscribe: Spotify | iHeartRadio | Email | Deezer | RSS | More

When your health is on the line, accurate diagnostics are crucial. But many blood tests suffer from false positives, false negatives, and frustrating gray areas. In this episode of StartUp Health NOW, host Logan Plaster sits down with John Forrest, CEO & Co-founder of Veravas, a member of the StartUp Health community, to discuss their groundbreaking solution.

  • VeraBIND: Learn how Veravas’ patented technology cleans blood samples to remove impurities, dramatically increasing diagnostic accuracy and eliminating ambiguous results.
  • Transforming Alzheimer’s Detection: Find out how VeraBIND results in a test with a single result that says yes, you have the disease, or no, you don’t.
  • Beyond Blood: Explore the potential of VeraBIND to transform diagnostics for a wide range of diseases, even using saliva samples – which are much easier for older patients to manage on a regular basis.
  • The Future: Hear Forrest’s insights on the challenges and opportunities in the health tech industry and how Veravas is poised to make a significant impact.

Tune in for the conversation and learn how Veravas is turning the tide on diagnostic uncertainty.

 

Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is a benefit of our Health Moonshot Community Membership. To schedule a call and see if you qualify to join and increase brand awareness through our multi-media storytelling efforts, submit our three-minute application. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit.
» Learn more and apply today.

Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

Imaginostics: Brand New Technology for Preventative Health

Imaginostics Is Imagining Brand New Innovative, Non-Invasive Diagnostic Solutions for Health & Disease

Business, Health, Innovation, Startups, , , , , , , , , , , , , , , , , , , ,

Podcast: Play in new window | Download (54.3MB)

Subscribe: Spotify | iHeartRadio | Email | Deezer | RSS | More

What if a single scan could not only diagnose existing health issues but also predict future problems and help prevent them? That’s the groundbreaking vision behind Imaginostics, a startup co-founded by Codi Gharagouzloo, PhD. A new member of the StartUp Health community, Imaginostics creates innovative, non-invasive diagnostic solutions using breakthrough quantitative imaging biomarkers to provide new insight in health and disease.

In this episode, StartUp Health co-founder Unity Stoakes interviews Gharagouzloo during JPM Week in San Francisco to explore the science behind Imaginostics and the unique technology they’re developing to revolutionize preventative health. You’ll also hear Gharagouzloo’s fascinating founder journey, from a troublemaking youth to a physicist with a soul-deep passion for transforming healthcare.

With $5M raised and an FDA breakthrough designation in hand, Imaginostics is making waves. Don’t miss this inspiring story of innovation, passion, and the pursuit of better health for all.Tune in now!

 

Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is a benefit of our Health Moonshot Community Showcase Membership. To schedule a call and see if you qualify to join and increase brand awareness through our multi-media storytelling efforts, submit our three-minute application. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. Learn more and apply today.

Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

Breaking News: Sinaptica's Noninvasive Neuromodulation Device Slows Alzheimer’s Disease in Year-Long Trial

Breaking News: Sinaptica’s Noninvasive Neuromodulation Device Slows Alzheimer’s Disease in Year-Long Trial

Health, Innovation, Startups, , , , , , , , , , ,

Podcast: Play in new window | Download (15.6MB)

Subscribe: Spotify | iHeartRadio | Email | Deezer | RSS | More

Hear the latest groundbreaking news in Alzheimer’s research. Sinaptica, a member of StartUp Health’s Alzheimer’s Moonshot Community, has announced significant results from its Phase 2 clinical trial testing the company’s noninvasive, personalized, precise neuromodulation designed to stop the progression of Alzheimer’s disease.

Ken Mariash, CEO of Sinaptica, joined us in the StartUp Health Studio to break it all down for us. As you’ll hear, the interview took place prior to the release of this data, which became public on October 31.

In this exclusive interview, you’ll learn:

  • Details on Sinaptica’s Phase 2 trial results show significant promise in slowing Alzheimer’s progression
  • The science behind Sinaptica’s technology
  • How personalized neuromodulation is revolutionizing brain health
  • The potential for proactive brain strengthening and repair
  • The impact on patients’ daily lives
  • The future of Alzheimer’s treatment

This episode is a must-listen for anyone interested in Alzheimer’s research, neuroscience, and the power of innovation to transform lives.

Are you ready to tell your story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is a benefit of StartUp Health’s PRO Membership. To schedule a call and see if you qualify to join and increase brand awareness through our multi-media storytelling efforts, submit our three-minute application. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. Learn more and apply today.

Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

 

Are You Ready to Join a Health Moonshot Community?

Business, Health, Innovation, Startups, , , , , , , , ,

Podcast: Play in new window | Download (35.3MB)

Subscribe: Spotify | iHeartRadio | Email | Deezer | RSS | More

Want to be part of the StartUp Health community? This special episode of StartUp Health NOW goes behind the scenes here at StartUp Health as we unveil new health moonshot community offerings!

Join host Logan Plaster as he talks with the co-founders of StartUp Health, Steven Krein and Unity Stoakes, on the evolution of StartUp Health’s global community.

Discover:

  • An exciting new offering for the StartUp Health community
  • Exclusive events and a new member app fostering deeper connections
  • The unifying idea that fuels community success
  • How YOU can qualify for a health moonshot community and apply

This episode is a must-listen for anyone interested in the future of healthcare innovation and the power of community in driving change.

Listen now and learn how you can get involved!

 

Are you ready to join a Health Moonshot Community? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. Learn more and apply today.

Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

 

From Caregiver to Changemaker: Inside the Impact Board with Meryl Comer on Fighting Alzheimer’s

Business, Health, Innovation, Startups, , , , , , ,

Podcast: Play in new window | Download (38.1MB)

Subscribe: Spotify | iHeartRadio | Email | Deezer | RSS | More

This week on StartUp Health NOW, we meet a powerful force in the fight against Alzheimer’s disease: Meryl Comer, a member of our Alzheimer’s Moonshot Impact Board.

Driven by personal experience watching her husband battle the disease, Comer transformed from award-winning journalist to passionate advocate. She is the Co-founder & Board Member of UsAgainstAlzheimers; the U.S. Representative for the Global Brain Trust; and Vice-Chair of WHAM (Women’s Health Access Matters).

Hear her story:

  • Witnessing the devastating effects of Alzheimer’s firsthand
  • Taking action through co-founding UsAgainstAlzheimers
  • The critical role of advocacy and policy change
  • The emotional and physical burden of caregiving

Comer also shares her insights on:

  • Destigmatizing Alzheimer’s diagnosis
  • Anchoring innovation in the realities of care
  • Treating the source of the disease

This episode is a must-listen for anyone affected by Alzheimer’s, passionate about healthcare innovation, or inspired by the power of advocacy.

 

Are you ready to join a Health Moonshot Community? Members of our Health Moonshot Communities – like our Alzheimer’s Moonshot – are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. Learn more and apply today.

Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

Making Scientific Breakthroughs More Accessible

Bridging the Divide: How Mindr Is Bringing Alzheimer’s Research to Life

Business, Health, Innovation, Startups, , , , , ,

Podcast: Play in new window | Download (30.3MB)

Subscribe: Spotify | iHeartRadio | Email | Deezer | RSS | More

Alzheimer’s disease has long been a formidable challenge, but recent scientific breakthroughs offer a glimmer of hope. The FINGER study, a landmark in Alzheimer’s research, demonstrated the power of simple lifestyle changes in preventing cognitive decline. However, translating these findings into practical, everyday strategies has proven elusive.

In this episode of StartUp Health NOW, we explore how Mindr, a pioneering startup in our Alzheimer’s Moonshot Community, is bridging the gap between research – the FINGER study – and real-world application in the lives of people at risk for Alzheimer’s and dementia. By leveraging the best of modern consumer tech – like a well designed app on your phone – Mindr aims to make internationally-recognized advances in healthcare accessible to everyone.

This is a story that applies in almost every area of health. We have the information, but we struggle to get it out of the lab, out of the peer reviewed journal, and into everyday life. Mindr’s co-founders Adam Schultz and Ariana Myers explain how they’re attempting to bridge this divide and what it will take to succeed on a bigger scale.

Join us as we discuss the importance of connecting research to practice and how Mindr is empowering individuals to take proactive steps toward a healthier brain.

Innovating in Alzheimer’s disease? Learn how you can join our Alzheimer’s Moonshot.

Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

Old School + New School Tech = Big Impact

Old School Tech Makes Big Impact in Cognitive Care: Reporting from the Alzheimer’s Association International Conference

Business, Health, Innovation, Startups, , , , , , , , , , , , ,

Podcast: Play in new window | Download (34.3MB)

Subscribe: Spotify | iHeartRadio | Email | Deezer | RSS | More

This episode of StartUp Health NOW throws out the tech buzzwords and dives into the power of seemingly simple solutions. We meet two innovative founders in our Alzheimer’s Moonshot Community who are using familiar technologies – the telephone and television – to tackle major healthcare challenges.

  • First up, Paul Campbell, CEO & Co-founder of Moneta Health, explains how their evidence-based dementia care program utilizes an “old school meets new school” approach, using AI plus the humble landline to reach a wider audience and overcome tech barriers for patients with early-stage dementia and Alzheimer’s.
  • Then, Bill Uniowski, CEO & Co-founder of Zinnia, shares how his company is creating smart video content specifically designed for people with advanced dementia, offering a calming and therapeutic experience that reduces the need for medication and improves lives for both patients and caregivers.

Join us for a refreshing look at how low-tech solutions can deliver high-impact healthcare.

Innovating in Alzheimer’s disease? Learn how you can join our Alzheimer’s Moonshot.

Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

Innovators: Health Transformer University fuels your health moonshot

Funders: Become a Health Moonshot Champion